The global nutragenomics market size is expected to reach US$ 2.11 Billion in 2032. The nutragenomics market is growing rapidly.
As per FMI Analysts, the global Nutragenomics market is estimated to be valued at US$ 538.90 Million in 2022 and is projected to increase at a CAGR of 16.48% in the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Nutragenomics Market Estimated Base Year Value (2021) | US$ 462.97 Million |
| Nutragenomics Market Expected Market Value (2022) | US$ 538.90 Million |
| Nutragenomics Market Anticipated Forecast Value (2032) | US$ 2.11 Billion |
| Nutragenomics Market Projected Growth Rate (2022 to 2032) | 16.48% CAGR |
The prevalence of genetic and chronic diseases has significantly increased so consumers are now being asked to take a nutragenomics test to find out if they have a preexisting or upcoming health issue due to eating a particular food product, driving growth in the nutragenomics market. Manufacturers are also attempting to use this process in order to understand a product's effect on its intended consumer before releasing it on the market.
The consumption of diets containing phenylalanine may interfere with the synthesis of proteins and enzymes. Kits of nutragenomics are also helpful in tracking nutritional consumption in a particular area or country. Nutragenomics manufacturers may be able to provide these tests at affordable prices. They may also try using other techniques for nutragenomics analysis; they may also consider the time duration of the analysis.
Nutragenomics manufacturers will be able to develop a rapid interaction detection technique between food and genes, as well as the interaction of nutrients with health and disease if manufacturers concentrate on regions involving Europe, Japan, and the USA for the maximum purchase of such products.
In addition, nutragenomics manufacturers can devise such kits and reagents that are easy for users to use, and results may be obtained in less time than other techniques. Nutragenomics may also be used to determine the amount of nutrient consumption in a particular area, as well as determine the toxicity of any products that may be used in the manufacture of foods that could be harmful to human health, registering high growth rates in the global nutrigenomics market.
Over the forecast period, North America is expected to lead the global nutrition genomics market, driven by the rapid adoption of personal genomics, the rising number of service providers, and the increasing prevalence of lifestyle-related diseases.
Companies like this are focusing on merging and collaborating with research facilities to develop ideal genetic tests. The main hurdle for manufacturers is developing better testing kits and having them approved by regulatory agencies. This is a change that will help fuel the nutragenomics market in the future.
Earlier this year, 23&Me teamed up with GlaxoSmithKline to research and developed innovative medicine, using genetics as the foundation to develop possible cures. To advance the understanding of human genetic diversity and to improve health outcomes for underrepresented populations in genetic research, 23&Me launched The Global Genetic Project in February 2018.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The nutragenomics market has received a lot of traction in the industry.
Gene-related and chronic diseases are becoming more common, which is why some consumers are undergoing nutragenomics tests to understand their preexisting health conditions and any potential health issues that may occur if they consume a particular food product. Manufacturers are attempting to use nutragenomics to determine whether a product will have an adverse effect on the consumer before releasing it, creating demand for nutrigenomics.
Nutragenomics kits are useful for tracking nutrient intake amongst consumers in a particular area or country. Consumers should avoid consuming phenylalanine-containing foods since they could interfere with protein synthesis and enzyme synthesis.
Companies that specialize in these fields might be able to create tests at an affordable price, or they might be able to use other techniques rather than blood and saliva for nutragenomics analysis, or they might be able to reduce the time needed for the analysis.
The manufacturers of nutragenomics kits should consider targeting regions like Europe, Japan, and the USA so that their products can be sold in greater numbers, such as kits used for their stringent and precise regulation of any food material. Integrating biological data sets along with nutragenomics approaches could lead to the development of a rapid interaction detection technique between food and genes as well as the relationship between nutrients and health, resulting in an increase in sales of nutrigenomics.
The North American nutrigenomics market is expected to outpace its global counterpart over the forecast period owing to the rapid adoption of personal genomics, the increase in the number of service providers, and the rising prevalence of lifestyle-related diseases.
It is predicted that the nutrigenomics market in Europe will expand during the forecast period as a result of increased research, strategic collaborations, and active government support.
The Asia Pacific is expected to drive notable growth in the nutragenomics market due to the large number of patients suffering from lifestyle diseases, in addition to lucrative pricing strategies being applied by various start-up companies in these regions.
According to a survey by a research institution in nine countries with 9000 participants, nutrigenomics has been widely accepted, and people are ready to adopt it if offered a legal guarantee that genetic data will not be misused. The Asia Pacific region is also expected to experience strong growth in the nutragenomics market due to the growing demand for functional foods and beverages that have elevated the adoption of nutrigenomic techniques.
Principal Consultant
Some of the leading companies operating in the global nutragenomics market include Koninklijke DSM N.V., BASF SE, Danone SA, Genova Diagnostics, Inc., Nutrigenomix Inc., The Unilever Group, XCode Life Sciences Private Limited, WellGen, Inc., Integrative Medicine Communications. Inc., and Receptor Logic, Inc.
There are many companies that are focusing on acquiring and collaborating with various facilities for the development of ideal genetic tests. The development of better testing kits and their approval by regulatory bodies is the main hurdle facing all of these companies, and these changes will help propel the nutragenomics market growth in the future.
A collaboration between 23&Me and GlaxoSmithKline took place in June 2018. This collaboration will focus on investigating and developing innovative medicines and potential cures using human genetics as a starting point.
With the launch of The Global Genetic Project in February 2018, 23&Me seeks to improve its understanding of human genetic diversity and provide insights into health conditions that may affect populations underrepresented in genetic research, thereby affecting the growth rate in the global nutragenomics market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 16.48% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global nutrigenomics market is set to exceed US$ 2.11 Billion by 2032.
The USA is projected to lead the nutrigenomics market in the forecast period.
Koninklijke DSM N.V., BASF SE, Danone SA, and Genova Diagnostics, Inc. are some of the renowned companies in the nutrigenomics market.
1. Global Market Executive Summary | Nutragenomics Market
1.1. Global Market Overview
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Fact.MR Analysis and Recommendations
2. Global Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Introduction and Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Nutragenomics
3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices
3.1.3. COVID-19 Impact Benchmark with Previous Crisis
3.1.3.1. Change in Demand
3.1.3.2. Before and After COVID-19 Crisis (Projected)
3.1.3.3. Before and After Sub-prime Crisis - 2008 (Actual)
3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)
3.1.4. Impact on Market and Value (US$ Million)
3.1.4.1. Likely Loss of Value in 2020
3.1.4.2. Mid-term and Long-Term Forecast
3.1.4.3. Quarter-by-Quarter Demand and Recovery Assessment
3.1.5. Anticipated Demand and Value Recovery Curve
3.1.5.1. Likelihood of U-Shape Recovery
3.1.5.2. Likelihood of L-Shape Recovery
3.1.6. Recovery Period Assessment by Key Countries
3.1.7. Recovery Assessment by Key Market Segments
3.1.8. Action Points and Recommendations for Suppliers
3.1.9. Impact on Trade Balance
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and foundation Data Points
4.1. Need of the Hour for Industries
4.2. Industry Wise Industry 4.0
4.3. Strategic Priorities
4.4. Life Cycle Stage
4.5. Importance of Technology
4.6. Use Cases of Nutragenomics
4.7. Forecast Factors: Relevance and Impact
4.8. Investment Feasibility Matrix
4.9. PESTLE Analysis
4.10. Porter’s Five Forces Analysis
4.11. Market Dynamics
4.11.1. Drivers
4.11.2. Restraints
4.11.3. Opportunity Analysis
4.11.4. Trend
5. Global Market Demand (US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
5.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021
5.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Value (US$ Million) Analysis By Product, 2017 to 2021
6.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032
6.3.1. Services
6.3.2. Reagents & Kits
6.4. Market Attractiveness Analysis By Product
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Technique
7.1. Introduction / Key Findings
7.2. Historical Market Value (US$ Million) Analysis By Technique, 2017 to 2021
7.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Technique, 2022 to 2032
7.3.1. Blood
7.3.2. Saliva
7.3.3. Buccal Swab
7.3.4. Others
7.4. Market Attractiveness Analysis By Technique
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Million) Analysis By Application, 2017 to 2021
8.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
8.3.1. Diabetics Pharmaceuticals
8.3.2. Cardiovascular
8.3.3. Anti-aging
8.3.4. Chronic Diseases
8.3.5. Others
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Million) Analysis By Region, 2017 to 2021
9.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia & Oceania
9.3.6. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.3. Market Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.3.1. By Country
10.3.1.1. USA
10.3.1.2. Canada
10.3.2. By Product
10.3.3. By Technique
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product
10.4.3. By Technique
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Product
11.3.3. By Technique
11.3.4. By Application
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Technique
11.4.4. By Application
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. Spain
12.3.1.5. United Kingdom
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Product
12.3.3. By Technique
12.3.4. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Technique
12.4.4. By Application
13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Product
13.3.3. By Technique
13.3.4. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Technique
13.4.4. By Application
14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Malaysia
14.3.1.4. Singapore
14.3.1.5. Vietnam
14.3.1.6. Australia and New Zealand
14.3.1.7. Rest of South Asia & Oceania
14.3.2. By Product
14.3.3. By Technique
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Technique
14.4.4. By Application
15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. Israel
15.3.1.4. Rest of Middle East and Africa (MEA)
15.3.2. By Product
15.3.3. By Technique
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Technique
15.4.4. By Application
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.4. Koninklijke DSM N.V.
17.4.1. Company Overview
17.4.2. Product Overview
17.4.3. SWOT Analysis
17.4.4. Key Developments
17.5. BASF SE
17.5.1. Company Overview
17.5.2. Product Overview
17.5.3. SWOT Analysis
17.5.4. Key Developments
17.6. Danone SA
17.6.1. Company Overview
17.6.2. Product Overview
17.6.3. SWOT Analysis
17.6.4. Key Developments
17.7. Genova Diagnostics, Inc.
17.7.1. Company Overview
17.7.2. Product Overview
17.7.3. SWOT Analysis
17.7.4. Key Developments
17.8. Nutrigenomix Inc.
17.8.1. Company Overview
17.8.2. Product Overview
17.8.3. SWOT Analysis
17.8.4. Key Developments
17.9. The Unilever Group
17.9.1. Company Overview
17.9.2. Product Overview
17.9.3. SWOT Analysis
17.9.4. Key Developments
17.10. XCode Life Sciences Private Limited
17.10.1. Company Overview
17.10.2. Product Overview
17.10.3. SWOT Analysis
17.10.4. Key Developments
17.11. WellGen, Inc.
17.11.1. Company Overview
17.11.2. Product Overview
17.11.3. SWOT Analysis
17.11.4. Key Developments
17.12. Integrative Medicine Communications. Inc.
17.12.1. Company Overview
17.12.2. Product Overview
17.12.3. SWOT Analysis
17.12.4. Key Developments
17.13. Receptor Logic, Inc.
17.13.1. Company Overview
17.13.2. Product Overview
17.13.3. SWOT Analysis
17.13.4. Key Developments
17.14. Vizag Chemical International
17.14.1. Company Overview
17.14.2. Product Overview
17.14.3. SWOT Analysis
17.14.4. Key Developments
18. Assumptions And Acronyms Used
19. Research Methodology
Explore Food and Beverage Insights
View Reports
Nutragenomics Market
